FORTE BIOSCIENCES INC's ticker is FBRX and the CUSIP is 34962G109. A total of 48 filers reported holding FORTE BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,815 | -49.1% | 26,911 | -20.0% | 0.00% | – |
| Q2 2023 | $34,977 | +28.7% | 33,632 | +25.0% | 0.00% | – |
| Q1 2023 | $27,180 | +3.0% | 26,911 | +2.0% | 0.00% | – |
| Q4 2022 | $26,379 | -5.8% | 26,379 | 0.0% | 0.00% | – |
| Q3 2022 | $28,000 | +7.7% | 26,379 | +33.4% | 0.00% | – |
| Q2 2022 | $26,000 | -82.8% | 19,767 | -80.9% | 0.00% | – |
| Q1 2022 | $151,000 | -33.5% | 103,305 | -2.5% | 0.00% | – |
| Q4 2021 | $227,000 | -27.5% | 105,906 | +0.0% | 0.00% | – |
| Q3 2021 | $313,000 | -75.8% | 105,855 | +174.7% | 0.00% | – |
| Q2 2021 | $1,296,000 | +82.5% | 38,536 | +86.1% | 0.00% | – |
| Q1 2021 | $710,000 | -4.4% | 20,712 | +1.5% | 0.00% | – |
| Q4 2020 | $743,000 | -21.5% | 20,408 | +4.6% | 0.00% | – |
| Q3 2020 | $946,000 | +1503.4% | 19,504 | +384.6% | 0.00% | – |
| Q2 2020 | $59,000 | – | 4,025 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 84,989 | $3,094,000 | 1.41% |
| BVF INC/IL | 718,788 | $26,171,000 | 1.03% |
| ArrowMark Colorado Holdings LLC | 2,936,708 | $106,926,000 | 0.83% |
| MYDA Advisors LLC | 28,000 | $1,019,000 | 0.30% |
| Maven Securities LTD | 83,374 | $3,036,000 | 0.30% |
| Parkman Healthcare Partners LLC | 31,098 | $1,132,000 | 0.29% |
| Woodline Partners LP | 192,266 | $7,000,000 | 0.19% |
| Sepio Capital, LP | 58,591 | $2,133,000 | 0.18% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 325,000 | $11,833,000 | 0.17% |
| Perceptive Advisors | 350,000 | $12,744,000 | 0.14% |